Medication and Management of Asthma in the Elderly

Qiu-hui WU,Wei HU,Hai-xia ZHANG,Jin-ping ZHANG,Wei-hong GE

DOI: https://doi.org/10.13664/j.cnki.pcr.2015.03.023

2015-01-01

Abstract:This article summarizes the progress of asthma medication in elderly, presenting the pharmacist-led asthma management, in order to enable a more rational medication of asthma and also to improve the control level of asthma in elderly.

What problem does this paper attempt to address?

Factors of poor elderly asthma control and strategies for improvement

吴秋惠,张桂凡,胡巍,张海霞,葛卫红

DOI: https://doi.org/10.3969/j.issn.1009-6469.2016.10.051

2016-01-01

Abstract:This paper summarizes the factors of poor asthma control in the elderly,and proposes strategies for improvement,in order to improve the current situation of poor asthma control in the elderly,including improvement in the administration of asthma in the elderly, increase in the compliance of patients with asthma.
Pharmaceutical Interventions by Collaboration Between Staff Pharmacists and Clinical Pharmacists and Implementation of Joint Commission International Accreditation Standards on Medication Use May Optimize Pharmacotherapy in Geriatric Patients

M Chen,Q Zhou

DOI: https://doi.org/10.2147/cia.s123900

2016-01-01

Abstract:Pharmaceutical interventions by collaboration between staff pharmacists and clinical pharmacists and implementation of Joint Commission International Accreditation Standards on medication use may optimize pharmacotherapy in geriatric patients Meng Chen, Quan Zhou Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of ChinaWe read with great interest the prospective study by Cortejoso et al,1 which describes the characteristics of pharmaceutical interventions in two geriatric wards (orthogeriatric ward and geriatric day unit) of a general teaching hospital. We strongly agree with their finding that shows the importance of clinical pharmacist involvement in the optimization of pharmacotherapy in elderly patients. Furthermore, we especially appreciate their new and interesting findings that the clinical pharmacist was more frequently requested by physicians and nurses for information about the pharmacotherapy of the patients on the geriatric day unit, compared with the orthogeriatric ward at admission and discharge (5.7% vs 1.2% and 1.7%, respectively, P<0.05), and that the pharmacist asked for more confirmation of the physician orders on the geriatric day unit rather than the orthogeriatric ward (19.8% vs 1.8% and 15.7% at admission and discharge, respectively, P<0.05). We are from a Joint Commission International (JCI)-accredited academic medical center hospital with 3200 beds in China. Safe medication management and use are pivotal to patient safety and quality of care on which the state-of-the-art standards of the Joint Commission focus. We would like to share our perspectives in the following paragraphs.View original paper by Cortejoso and colleagues.
Asthma in the elderly: a different disease?

Salvatore Battaglia,Alida Benfante,Mario Spatafora,Nicola Scichilone

DOI: https://doi.org/10.1183/20734735.002816

2016-03-01

Breathe

Abstract:Key points Asthma in the elderly can be difficult to identify due to modifications of its clinical features and functional characteristics. Several comorbidities are associated with asthma in the elderly, and this association differs from that observed in younger patients. In clinical practice, physicians should treat comorbidities that are correlated with asthma ( i.e. rhinitis or gastro-oesophageal reflux), assess comorbidities that may influence asthma outcomes ( i.e. depression or cognitive impairment) and try to prevent comorbidities related to ‘drug-associated side-effects ( i.e. cataracts, arrhythmias or osteoporosis). “Geriatric asthma” should be the preferred term because it implies the comprehensive and multidimensional approach to the disease in the older populations, whereas “asthma in the elderly” is only descriptive of the occurrence of the disease in this age range. Educational aims To present critical issues in performing differential diagnosis of asthma in the elderly. To offer the instrument to implement the management of asthma in the most advanced ages. Asthma is a chronic airway disease that affects all ages, but does this definition also include the elderly? Traditionally, asthma has been considered a disease of younger age, but epidemiological studies and clinical experience support the concept that asthma is as prevalent in older age as it is in the young. With the ever-increasing elderly population worldwide, the detection and proper management of the disease in old age may have a great impact from the public health perspective. Whether asthma in the elderly maintains the same characteristics as in young populations is an interesting matter. The diagnostic process in older individuals with suspected asthma follows the same steps, namely a detailed history supported by clinical examination and laboratory investigations; however, it should be recognised that elderly patients may partially lose reversibility of airway obstruction. The correct interpretation of spirometric curves in the elderly should take into account the physiological changes in the respiratory system. Several factors contribute to delaying the diagnosis of asthma in the elderly, including the age-related impairment in perception of breathlessness. The management of asthma in advanced age is complicated by the comorbidities and polypharmacotherapy, which advocate for a comprehensive approach with a multidimensional assessment. It should be emphasised that older age frequently represents an exclusion criterion for eligibility in clinical trials, and current asthma medications have rarely been tested in elderly asthmatics. Ageing is associated with pharmacokinetic changes of the medications. As a consequence, absorption, distribution, metabolism and excretion of antiasthmatic medications can be variably affected. Similarly, drug-to-drug interactions may reduce the effectiveness of inhaled medications and increase the risk of side-effects. For this reason, we propose the term “geriatric asthma” be preferred to the more generic “asthma in the elderly”.
Deprescribing for Older Adults in the Community:Recent Developments and Implications for China

XU Yuanyuan,XU Zhijie,NI Yating,LIANG Xujian,HU Xueting,FANG Zheming,ZHU Yue,FANG Lizheng

DOI: https://doi.org/10.12114/j.issn.1007-9572.2022.0160

2022-01-01

Chinese General Practice

Abstract:It is a great challenge to ensure medication safety in healthcare for older adults, since polypharmacy in this group may increase the risk of potentially inappropriate medications, leading to adverse drug reactions, drug-drug interactions, hospitalizations, increased medical costs, and even deaths. Deprescribing improves patient prognosis and reduces adverse drug events through patient participation, and shared decision-making. The prevalence of multimorbidity and polypharmacy in older adults is notably in community care, the frontline for the management of use of multiple drugs. As primary care physicians have a deep understanding of patients' past and current diagnoses and treatments, they play a vital role in reviewing and managing patients' medications. However, there are few reports on deprescribing in primary care in China. We described the definition of deprescribing, and reviewed its recent advances, with a focus on the implementation process of deprescribing in the community, and the impact of deprescribing on chronic disease management by primary care physicians. This review may provide a reference for further study and policy making regarding deprescribing in the community in China.
Navigating biologic therapies in elderly asthma

HyeIn Ji,Laren D Tan,George W Hafzalla,Nolan Nguyen,Abdullah Alismail

DOI: https://doi.org/10.1016/j.rmed.2024.107655

Abstract:The prevalence of asthma among the elderly population has witnessed a notable rise, presenting unique challenges in diagnosis and management. Biologic therapies, such as omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab, and tezepelumab, have demonstrated efficacy in targeting specific pathways associated with severe asthma in elderly individuals. However, a significant research gap exists in the application of these therapies in elderly asthma patients. Despite the considerable size of the elderly asthma population and the social and economic burden that this specific demographic imposes on society, the available body of research catering to this group is limited. Notably, no RCTs have been expressly designed for the elderly across all asthma biologic therapies. Moreover, most RCTs have set upper age cutoffs, commonly 75 years old, and exclusion criteria for common comorbidities in the elderly, thus marginalizing this group from pivotal research. This underscores the crucial need for intentional inclusion of elderly participants in separately designed clinical trials and more researches, aiming to augment the generalizability of findings and enhance therapeutic outcomes. Given the distinct physiological changes associated with aging, there may be a concern regarding the efficacy and safety of biologic therapies in the elderly compared to non-elderly adults, posing a barrier to their use in this population. However, observational studies have shown similar benefits of these therapies in elderly individuals as seen in non-elderly adults. Other anticipated challenges related to initiating biologic therapy in elderly people with asthma including dosing consideration and monitoring strategies, which are important areas of investigation for optimizing asthma management will be discussed in this review. In summary, this review navigates the current landscape of biologic therapies for elderly asthma, offering valuable insights for various stakeholders, including researchers, healthcare providers, and policymakers, to advance asthma care in this vulnerable population. We propose that future research should concentrate on tailored, evidence-based approaches to address the undertreatment of elderly asthma patients.
Management of Elderly Asthma: Key Questions and Tentative Answers

Heung-Woo Park,Sang Heon Cho

DOI: https://doi.org/10.4168/aair.2023.15.1.8

Abstract:The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?; 2) How can we appropriately diagnose EA?; 3) Are there management strategies specific to EA? Based on recent studies, we provide tentative answers as follows: 1) late-onset EA differs in clinical features and pathogenetic mechanisms from non-EA, and thus further phenotypic and endotypic characterization of EA is needed; 2) both over- and under-diagnosis of asthma in the elderly can be reduced if the objective diagnostic tests are appropriately performed; 3) cautious prescription of ICS to selected EA patients should be encouraged, and a multifaceted approach which involves increasing medical awareness and inhaler use proficiency and adherence, seeking the assistance of caregivers, and correcting micronutrient deficiencies is required to reduce acute exacerbations in EA patients.
An Epidemiological Survey on Clinical Features, Self-Management and Cognitive Level of Elderly Asthmatics in China

W Y Wang,J T Lin,X Zhou,P Chen,H Y Wan,K S Yin,L J Ma,C G Wu,J Li,C T Liu,H Xie,W Tang,M Huang,Y Chen,Y H Liu,L Q Song,X L Chen,G L Liu,Y M Zhang,W Li,L C Sun

DOI: https://doi.org/10.3760/cma.j.cn112137-20191117-02498

2020-01-01

Abstract:Objective:To investigate the prevalence of asthma among the elderly people in China and to analyze the clinical features, self-management and cognitive level of elderly asthma patients.Methods:According to the multi-stage random cluster sampling methods, a total of 164 215 subjects were visited by a questionnaire in the last epidemiology survey from eight provinces (Beijing, Shanghai, Guangdong, Liaoning, Henan, Shanxi, Jiangsu, Sichuan provinces) and seven regions (north, northeast, southern china, east, south, southwest and northwest) in China from February 2010 to August 2012. 2 034 were diagnosed as asthma. The elderly patients aged ≥65 years were selected from the 2 034 asthma patients. The clinical characteristics, comorbidities, the status of asthma control and self-management and insights of the disease in elderly asthma patients were analyzed.Results:Among the 2 034 asthma patients, 584 (28.7%) were elderly asthmatics aged ≥65 years old and 1 450 (71.3%) were<65 years old. In the elderly asthma group, Early-onset asthma accounted for 439 (75.2%) and 145 (24.8%) were late-onset. The common clinical manifestations of elderly asthma patients were: chest distress 395 (67.6%), wheezing 304 (52.1%), cough 298 (51.0%). Common comorbidities of elderly asthmatics were: chronic obstructive pulmonary disease 144 (24.7%), allergic rhinitis 122(20.9%), gastroesopheal reflux disease (GERD) 114(19.5%), allergic conjunctivitis 86 (14.7%), eczema 82 (14.0%), chronic bronchitis 76 (13.0%). The Asthma Control Test (ACT) scores of elderly asthmatics and non-elderly asthmatics were (18.5±3.2) and (21.7±3.4) respectively. There was a significant difference between the two groups ( P=0.042). Of the elderly asthmatics, only 13 (2.2%) patients monitored daily using a peak flow meter. 93 (15.9%) patients aware that asthma was characterized by chronic airway inflammation. 64 (11.0%) asthmatics understood that the treatment goal. Conclusions:The clinical manifestations of elderly asthmatics are atypical, especially paroxysmal wheezing. Asthma in elderly people causes more comorbidities and mortality. The self-management and cognitive level of patients with asthma needs to be improved.
Asthma in the elderly: a brief report.

A Apter,L C Grammer,B Naughton,R Patterson

DOI: https://doi.org/10.2500/108854188778995011

1988-01-01

Abstract:Asthma in the elderly may present difficult management problems. We reviewed 46 elderly patients with corticosteroid dependent asthma who have been managed on our ambulatory service for an average of nine years. We present our therapeutic regimens which resulted in better control for the majority of patients. The goals of therapy were control of asthma to prevent status asthmaticus which is potentially fatal asthma. In those patients who did not improve, inability to comply with our regimens was a major factor.
The Pharmacological Approach to the Elderly COPD Patient

Timothy E. Albertson,Michael Schivo,Amir A. Zeki,Samuel Louie,Mark E. Sutter,Mark Avdalovic,Andrew L. Chan

DOI: https://doi.org/10.1007/s40266-013-0080-1

2013-04-12

Abstract:The elderly patient (65 years and older) with chronic obstructive pulmonary disease (COPD) can be a challenge to the clinician. This begins with the correct and early diagnosis, the assessment of disease severity, recognizing complicating comorbidities, determining the burden of symptoms, and monitoring the frequency of acute exacerbations. Comprehensive management of COPD in the elderly patient should improve health-related quality of life, lung function, reduce exacerbations, and promote patient compliance with treatment plans. Only smoking cessation and oxygen therapy in COPD patients with hypoxemia reduce mortality. Bronchodilators, corticosteroids, methylxanthines, phosphodiesterase-4 inhibitors, macrolide antibiotics, mucolytics, and pulmonary rehabilitation improve some outcome measures such as spirometry measures and the frequency of COPD exacerbations without improving mortality. International treatment guidelines to reduce symptoms and reduce the risk of acute exacerbations exist. Relief of dyspnea and control of anxiety are important. The approach to each patient is best individualized. Earlier use of palliative care should be considered when traditional pharmacotherapy fails to achieve outcome measures and before consideration of end-of-life issues.

pharmacology & pharmacy,geriatrics & gerontology,gerontology
Pulmonary drug delivery to older people

Martin Wallin,Tatsuaki Tagami,Lan Chen,Mingshi Yang,Hak-Kim Chan

DOI: https://doi.org/10.1016/j.addr.2017.11.010

IF: 16.1

2018-10-01

Advanced Drug Delivery Reviews

Abstract:Pulmonary diseases, such as asthma and chronic obstructive pulmonary disease (COPD), are common in older people. Treatment principles are well established in this group of patients; however, inadequate training and improper inhaler techniques often results in poor treatment outcomes. Healthcare professionals often do not have the required knowledge about the most common inhaler devices. Age-related conditions like cognitive ability and physical strength would also impact on the inhaler usage. Pharmacokinetics and pharmacodynamics may be affected by physiological changes, like impaired renal and hepatic functions and reduced lung functions. Adjusting and optimizing the inhaler device to the patient preferences, improvement of the drug formulation and inhalers, and using different adherence strategies might improve the treatment outcomes in elderly patients.

pharmacology & pharmacy
Expert consensus recommendations for the management of asthma in older adults

Miguel Perpiñá,Ana Gómez-Bastero,Andrea Trisán,Eva Martínez-Moragón,Francisco Javier Álvarez-Gutiérrez,Isabel Urrutia,Marina Blanco-Aparicio

DOI: https://doi.org/10.1016/j.medcli.2021.04.028

2022-07-08

Abstract:Asthma is a public health problem in patients of any age, although there is still a tendency to erroneously assume that it is almost always confined to children and young people. Epidemiological studies indicate that, from the sixth decade of life, the prevalence of this disease in countries such as Spain reaches 6-10%, with a higher prevalence among women aged 64 to 75 years. In addition, two-thirds of asthma deaths occur at this stage of life, resulting in a substantial number of hospital admissions, longer hospital stays and, from a finance point of view, significant direct economic costs. Asthma in older adults (65 years or older) is now a matter of great concern, the reality of which is underestimated and undertreated. It is therefore essential to establish appropriate recommendations for the diagnosis and treatment of asthma in the aging population. This consensus, which brings together the latest evidence available, was conceived with this objective. The proposed recommendations/conclusions are the result of a nominal consensus developed throughout 2019 and validated by panellists in successive rounds of voting.
Exploring the potential mechanisms of Mahuang Fuzi Xixin decoction in treating elderly bronchial asthma through network pharmacology, molecular docking, and molecular dynamics simulations

Hongpeng Yu,Xiaotong Wei,Huan Ding,Shaodan Hu,Feng Sun,Zhenghua Cao,Li Shi

DOI: https://doi.org/10.1097/md.0000000000039921

IF: 1.6

2024-10-15

Medicine

Abstract:Bronchial asthma is a heterogeneous disease characterized by chronic hyperreactive airway inflammation. Typical symptoms include rapid breathing, coughing, expectoration, chest tightness, and episodic nocturnal dyspnea. [ 1 ] This illness can occur at any age but is more prevalent among children and the elderly. In recent years, the incidence of elderly bronchial asthma has been rising due to factors such as air pollution, respiratory viral infections, and the global increase in the aging population. [ 2 ] While the clinical symptoms in the elderly are similar to those in younger individuals, the physiological state of older adults is distinct. Their bodily functions gradually deteriorate, and their immune system function declines. Many elderly patients also suffer from multiple underlying diseases, which can prolong the duration of the illness. If not controlled timely, an episode can rapidly worsen, leading to severe respiratory distress and potentially life-threatening conditions. [ 3 ] Consequently, the proportion of severe cases among elderly bronchial asthma patients is relatively high, further increasing their mortality risk and gradually becoming a significant public health issue. [ 4 ] Clinically, Western medicine often employs corticosteroids, antibiotics, and bronchodilators to manage respiratory symptoms. However, the effectiveness of these treatments is limited, leading to recurrent coughing after discontinuation of the medication and even long-term coughing and wheezing. [ 5 ]

medicine, general & internal
Age-Related Clinical Characteristics, Inflammatory Features, Phenotypes, and Treatment Response in Asthma

Ji Wang,Xin Zhang,Li Zhang,Ying Liu,Gang Wang,Hong Ping Zhang,Lei Wang,De Ying Kang,Brian G. Oliver,Hua Jing Wan,Vanessa M. McDonald,Alan Chen-Yu Hsu,Dan Liu,Wei Min Li,Surinder S. Birring

DOI: https://doi.org/10.1016/j.jaip.2022.09.029

2023-01-01

Abstract:BACKGROUND: Emerging evidence suggests that aging affects asthma outcomes, but the mechanism remains largely unexplored.OBJECTIVE: To explore age-related clinical characteristics, in-flammatory features, phenotypes, and treatment response in asthma.METHODS: This was a prospective cohort study of asthmatic patients with a 12-month follow-up in a real-world setting. Clinical inflammatory and phenotypic characteristics, future risk for exacerbations, and treatment response were assessed across different age groups (young was defined as age 18 to 39 years; middle-aged, 40 to 64 years; and elderly, 65 years or older). RESULTS: Compared with young (n = 106) and middle-aged (n = 179) asthmatic patients, elderly patients (n = 55) had worse airway obstruction, more comorbidities including chronic obstructive pulmonary disease and diabetes, less atopy, and lower levels of IgE and FeNO, and were more likely to have late-onset and fixed airflow obstruction asthma and a reduced risk for having type 2 profile asthma. Levels of IFN-gamma, IL-17A, and IL-8 in induced sputum were significantly increased in elderly asthmatic patients (all P < .05). Path analysis indicated that age directly and significantly led to future exacerbations in asthma, partially mediated by an upregulation of airway IFN-gamma. Moreover, elderly pa-tients with asthma had a reduced treatment response (improvement in FEV1 of 12% or greater, or 200 mL, and a reduction in Borg scores of 1 or greater) (adjusted odds ratio = 0.11; 95% CI, 0.02-0.52; and adjusted odds ratio = 0.12; 95% CI, 0.03-0.49, respectively).CONCLUSIONS: This study confirms that asthma in the elderly population represents a specific phenotype and indicates that aging can influence asthma in terms of clinical characteristics, inflammatory features, exacerbations, and treatment response.(c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:210-9)
Diagnosis and management of asthma in the elderly

M Zhang,X Zhou

DOI: https://doi.org/10.3760/CMA.J.ISSN.0376-2491.2019.16.002

2019-01-01

Abstract:: 老年期为第二个哮喘发病高峰期。由于老年人生理功能衰退、并发症及感觉迟钝等原因，老年哮喘在诊断和治疗上存在特殊性。针对老年哮喘，应更加重视详实的病史采集，开发适用于此类患者的特殊客观检查及判定阈值尽可能降低漏诊率和误诊率，并兼顾合并症、药代动力学等制定相对个性化的管理策略，提高其预后和生活质量。.
Advances in the management of elderly patients with advanced non-small cell lung cancer

Wa CAO,Xiao-xia CHEN,Cai-cun ZHOU

DOI: https://doi.org/10.3781/j.issn.1000-7431.2015.55.007

2015-01-01

Tumori

Abstract:Lung cancer is a disease of the elderly. Nowadays, the management of elderly patients with non-small cell lung cancer (NSCLC) is challenging. Despite the fact that more than 50% of patients with NSCLC are elderly (u003e 70 years old), information remains scant on these patients. Many older patients with advanced NSCLC do not receive or have lost the chance of optimal management. The goal of this review is to sort and analyze the information obtained from published literatures and to provide guidance on how to treat elderly patients with advanced NSCLC more appropriately. DOI:10.3781/j.issn.1000-7431.2015.55.007
Building Medication Profiles in the Elderly: a Qualitative Study Based on Medication Information Literacy in a Long-Term Care Facility

Xiaoyu Zhou,Fei Du,Wei Peng,Li Bai,Leyi Peng,Xiaorong Hou

DOI: https://doi.org/10.2147/cia.s454620

IF: 3.829

2024-05-11

Clinical Interventions in Aging

Abstract:Xiaoyu Zhou, 1– 3 Fei Du, 1– 3 Wei Peng, 4 Li Bai, 5 Leyi Peng, 1– 3 Xiaorong Hou 1– 3 1 College of Medical Informatics, Chongqing Medical University, Chongqing, 400016, People's Republic of China; 2 Medical Data Science Academy, Chongqing Medical University, Chongqing, 400016, People's Republic of China; 3 Chongqing Engineering Research Center for Clinical Big Data and Drug Evaluation, Chongqing, 400016, People's Republic of China; 4 The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400042, People's Republic of China; 5 Hospital of Zigong Mental Health Central, Sichuan, 643021, People's Republic of China Correspondence: Xiaorong Hou, Chongqing Medical University, No. 1, Medical College Road, Yuzhong District, Chongqing, 400016, People's Republic of China, Email Purpose: Long-term care facilities are increasingly challenged with meeting the diverse healthcare needs of the elderly population, particularly concerning medication management. Understanding medication information literacy and behavior among this demographic is imperative. Therefore, this qualitative study aims to explore medication information literacy and develop distinct medication profiles among elderly long-term care residents. Material and Methods: In this study, we conducted in-depth semi-structured interviews with 32 participants aged 65 or older residing in a long-term care facility. The interviews were designed to explore participants' understanding of medication information, medication management practices, and experiences with healthcare providers. Thematic analysis was employed to analyze the interview data, allowing for the identification of common patterns and themes related to medication-taking behavior among the elderly residents. Results: The thematic analysis revealed four distinct medication behavior profiles among the elderly long-term care residents: (1) Proactive Health Self-Managers, (2) Medication Information Adherents, (3) Experience-Based Medication Users, and (4) Nonadherent Medication Users. These findings provide valuable insights into the diverse approaches to medication management within long-term care facilities and underscore the importance of tailored interventions to support the specific needs of each profile. Conclusion: This study highlights the necessity for tailored medication education and support to optimize medication management for the elderly. With the aging population expansion, addressing the unique medication challenges within long-term care facilities becomes increasingly critical. This research contributes to ongoing endeavors to enhance healthcare services for the elderly, striving for safer and more effective medication-taking behavior. Keywords: medication information literacy, medication profile, long-term care facility, qualitative study, elderly As the phenomenon of population aging becomes increasingly prominent, society's focus has increasingly turned to the health status and medical requirements of the elderly. 1,2 Within this framework, medication-related issues among the elderly have gained significant traction within the healthcare domain. Elderly individuals, who often grapple with multiple chronic conditions, rely on a diverse array of medications to maintain their well-being. However, the complexity of managing multiple medications, commonly referred to polypharmacy, 3 can lead to complications such as drug interactions, medication errors, and adverse reactions, all of which can impact the health and overall quality of life of the elderly. 4,5 Of particular concern are the distinctive challenges that elderly individuals encounter in the realm of medication management. These challenges include cognitive decline, the intricacies of managing multiple medications, and the need for coordination among various healthcare providers. 6–9 These factors collectively increase the risk of medication errors among this demographic. In response to these challenges, medication information literacy has emerged as a critically important concept. Medication information literacy refers to a set of abilities wherein individuals recognize their medication information needs, possess familiarity with potential information sources, and effectively utilize them to obtain pertinent information. 10,11 It involves evaluating the quality of medication information and its applicability to a specific situation, as well as analyzing, understanding, and using medication information to make informed medication decisions. 12 For the elderly population, possessing a solid foundation in medication information literacy assumes paramount significa -Abstract Truncated-

geriatrics & gerontology,gerontology
Medication adherence in the older adults with chronic multimorbidity: a systematic review of qualitative studies on patient's experience

M Maffoni,S Traversoni,E Costa,L Midão,P Kardas,M Kurczewska-Michalak,A Giardini

DOI: https://doi.org/10.1007/s41999-020-00313-2

Abstract:Purpose: Medication non-adherence represents a socially relevant challenge, particularly when interlinked to multiple chronic diseases and polypharmacy. Non-adherence rates affect treatment efficacy and increase health care costs. The aim of the study was to identify factors influencing medication adherence in the older adults through a systematic review of qualitative studies on patients' experience. Methods: Two electronic databases were searched for qualitative studies on medication adherence in chronic diseases (hypertension, heart disease, COPD, asthma) involving people aged 65 + . The systematic review was performed according to the PRISMA statement guidelines, employing theoretical frameworks of the ABC Taxonomy of patient adherence and Three Factor model of determinants of behaviour. Results: The initial database search identified 1234 records, of which 39 studies were considered eligible. Most of the studies focused on hypertension and were conducted in English-speaking countries. According to the ABC Taxonomy, Persistence and Implementation were the most often considered phases. Considering the Three Factor model, the most often reported themes were Information and Strategies upon being adherent. Stemming from the review findings and the patients' narratives, a new integrated model was proposed. It reports the patient's decisional flowchart describing barriers and facilitators (personal, social and environmental) to adherence. Conclusion: Medication adherence is a complex and multifaceted process. The implementation of theoretical frameworks along with a patient-centred perspective may provide clinicians with useful suggestions for clinical practice, enhancing the patient's ability to adhere.
Medication Adherence among the Older Adults: Challenges and Recommendations

Junjie Huang,Haoxiang Wang,Zhi‐Jie Zheng,Martin CS Wong

DOI: https://doi.org/10.12809/hkmj205108

2020-01-01

Abstract:Medication adherence among the older adults: challenges and recommendations Growing burden of the ageing populationsThere is an increasing burden of the elderly population in many countries, with an estimated total of 2.37 billion population aged >65 years globally by 2100. 1 In Hong Kong, the number of people aged >65 years is expected to increase from 1.19 million to 2.51 million from 2016 to 2046, then comprising more than one third of the total population. 2 The substantial increase in the elderly population will inevitably contribute to the burden of public health and healthcare service, with chronic diseases and multimorbidity being the critical challenges.
China Should Emphasize Key Issues Inherent in Rational Medication Management for the Elderly.

Qi Tang,Cao Wang,Wenhui Wu,Yu Cao,Gang Chen,Jun Lü

DOI: https://doi.org/10.5582/bst.2021.01254

2021-01-01

BioScience Trends

Abstract:According to China's Seventh National Census, 18.70% of a total of 1.41 billion people were 60 or older and 13.50% were 65 or older, so China's population is increasingly aging. In conjunction with China's socioeconomic and scientific and technological development and its promotion of medical insurance-related policies, rational medication management for the elderly is a concern in order to control the risk of polypharmacy. This paper summarizes and discusses the following five key issues inherent in rational medication management: i) an increase in serious polypharmacy and the potential risks of medication; ii) a lack of medication consultation service and medication withdraw without healthcare providers' supervision; iii) poor medication compliance among the elderly; iv) insufficient quantity and incompetence of pharmaceutical staffing; and v) limited awareness of pharmaceutical services and lack of trust in the ability of pharmacists. Based on a discussion of factors influencing these issues, suggestions have been put forward in the hopes that China emphasizes rational medication management in order to reduce the risk of polypharmacy and the disease burden of the elderly in China.
Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults

Shoab A Nazir,Marcia L Erbland

DOI: https://doi.org/10.2165/11316760-000000000-00000

Abstract:Chronic obstructive pulmonary disease (COPD) is a debilitating disease of the elderly that causes significant morbidity and mortality. Despite being a treatable and preventable disease, the prevalence continues to rise because of the worldwide epidemic of smoking. COPD is associated with enormous healthcare costs. It has systemic effects, and common co-morbid conditions such as cardiovascular disease, muscle wasting and osteoporosis may all be linked through a common systemic inflammatory cascade. Depression, anxiety and malnutrition are also common in elderly COPD patients. These factors not only affect quality of life (QOL) but also compliance with therapy. Malnutrition is an independent predictor of mortality and poor outcome. Spirometry is essential for the diagnosis of COPD, but the criteria defining airflow limitation are not clear cut for elderly patients and could result in over-diagnosis. However, older patients perceive their symptoms differently, and COPD could also be under-diagnosed in this population. Acute exacerbations result in worsening symptoms that necessitate additional treatment, and may cause a more rapid decline in lung function and QOL. The management of elderly patients with COPD should encompass a multidisciplinary approach. An evaluation of patients' nutritional status and mental health should be undertaken, in addition to assessing their lung function and functional impairment. Significant underlying co-morbidities should be evaluated and treated to derive the maximal benefit of therapy. Specific therapy for COPD should start with cessation of exposure to the most important risk factor, tobacco smoke. Smoking cessation rates in the elderly have not declined, and this may reflect an underlying reluctance by physicians to counsel and offer smoking cessation therapies to the elderly. Unlike oxygen therapy in hypoxaemic patients, bronchodilators and corticosteroids do not decrease mortality in COPD patients and they are primarily directed towards symptom relief. However, they do have a positive effect on QOL and exacerbation rates. The choice of delivery devices for inhaled medications is important in the elderly, and patients' inhaler technique and manual dexterity should be frequently assessed. Pulmonary rehabilitation and nutritional supplementation are other important components of care. End-of-life issues should be adequately addressed in the elderly with COPD, and an approach integrating curative and palliative interventions is recommended.

Medication and Management of Asthma in the Elderly

Factors of poor elderly asthma control and strategies for improvement

Pharmaceutical Interventions by Collaboration Between Staff Pharmacists and Clinical Pharmacists and Implementation of Joint Commission International Accreditation Standards on Medication Use May Optimize Pharmacotherapy in Geriatric Patients

Asthma in the elderly: a different disease?

Deprescribing for Older Adults in the Community:Recent Developments and Implications for China

Navigating biologic therapies in elderly asthma

Management of Elderly Asthma: Key Questions and Tentative Answers

An Epidemiological Survey on Clinical Features, Self-Management and Cognitive Level of Elderly Asthmatics in China

Asthma in the elderly: a brief report.

The Pharmacological Approach to the Elderly COPD Patient

Pulmonary drug delivery to older people

Expert consensus recommendations for the management of asthma in older adults

Exploring the potential mechanisms of Mahuang Fuzi Xixin decoction in treating elderly bronchial asthma through network pharmacology, molecular docking, and molecular dynamics simulations

Age-Related Clinical Characteristics, Inflammatory Features, Phenotypes, and Treatment Response in Asthma

Diagnosis and management of asthma in the elderly

Advances in the management of elderly patients with advanced non-small cell lung cancer

Building Medication Profiles in the Elderly: a Qualitative Study Based on Medication Information Literacy in a Long-Term Care Facility

Medication adherence in the older adults with chronic multimorbidity: a systematic review of qualitative studies on patient's experience

Medication Adherence among the Older Adults: Challenges and Recommendations

China Should Emphasize Key Issues Inherent in Rational Medication Management for the Elderly.

Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults